Abstract
Parkinson´s disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta, followed by motor and non-motor symptoms. Although dopaminergic reposition can treat motor symptoms, it does not interrupt PD progression. Therefore, several studies search strategies to revert the molecular alterations that trigger this disease, mitigating the ensuing neur…